共 31 条
[1]
Hwang TJ(2017)Value-based pricing and state reform of prescription drug costs JAMA 318 609-610
[2]
Kesselheim AS(2014)Sustainable health care systems: the role of therapeutic value and value based pricing Value Health 17 A452-95
[3]
Sarpatwari A(2013)Value based pricing: Can it work? BMJ 347 f5941-122
[4]
Hulshof JA(2017)The impact of HTA and procurement practices on the selection and prices of medical devices Soc Sci Med 174 89-30
[5]
Raftery J(2016)Pharmaceutical regulation in 15 European countries review Health Syst Transit 18 1-2504
[6]
Callea G(2014)Indication-specific pricing for cancer drugs JAMA 312 1629-453
[7]
Armeni P(2015)Payer and policy maker steps to support value-based pricing for drugs JAMA 314 2503-768
[8]
Marsilio M(2017)Incremental cost-effectiveness ratio and net monetary benefit: current use in pharmacoeconomics and future perspectives Eur J Intern Med 43 e36-152
[9]
Jommi C(2017)Presenting the results of a pharmacoeconomic study: incremental cost-effectiveness ratio vs net monetary benefit Heart 103 1746-378
[10]
Tarricone R(2016)International Carotid Stenting Study investigators. Cost-utility analysis of stenting versus endarterectomy in the International Carotid Stenting Study Int J Stroke 11 446-undefined